Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy

  • Nagahide Matsumura, Yasushi Nakamura, Yasuo Kohjimoto, Satoshi Nishizawa, Kazuro Kikkawa, Akinori Iba, Yoshiki Kodama, Isao Hara
  • International Journal of Urology, January 2017, Wiley
  • DOI: 10.1111/iju.13274

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/iju.13274

In partnership with: